Clinical Trial Update: Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy [NA]

View source ↗

Summary

A completed clinical trial assessing microperimetric outcomes after half-dose photodynamic therapy for chronic central serous chorioretinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Visudyne (verteporfin)

Snippet

Sponsor: Surugadai Nihon University Hospital | Conditions: Chronic Central Serous Chorioretinopathy | NA | Status: COMPLETED